A key lesson learned in 2020 was the importance of rapid discovery of novel molecules and transition into scale up. Advancement of technologies in flow chemistry and control systems have enabled Discovery Chemists, Process Chemists, PAT and Engineers to adopt flow chemistry to uncover previously inaccessible APIs and synthetic molecules – with a much more streamlined development process, in addition to the increased emphasis of green chemistry.
The 2nd Annual Commercializing Flow Chemistry Summit will return to bridge the gap between academic and industry innovation this August, as the only truly application focused event, to translate exciting theory into commercial reality. Joined by 100+ senior leaders from large pharma, biotech, academia; including exploration outside of pharma for the first time.
Don’t miss out on this unique opportunity to go beyond on the bench and make real impact to your company.
Moderated By
Flavien Susanne
Head of Chemical
Development and Engineering
Sanofi
Oliver Kappe
Professor, Scientific Director
University of Graz, Center for Continuous Flow Synthesis and Processing (CC FLOW)
Feedback from Commercializing Flow Chemistry Summit 2020
“A diverse group of talks from key leaders in the field, covering all aspects of developing and implementing flow chemistry in DS and DP manufacturing.”
- Immunogen
“The CFC meeting was a terrific snapshot at the cutting-edge of this rapidly developing field.”
- Continuity Pharma